Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental Illness

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-55
SponsorMassachusetts General Hospital

About this trial

The proposed research will test the hypothesis that objective social isolation and loneliness are linked to neurobehavioral mechanisms involved in social perception and motivation in individuals with and without serious mental illness. Moreover, it will investigate the specific dynamic interactions among these experiences in daily life and how they, and their neurobehavioral predictors, are linked to day-to-day functioning. The findings of this project could provide novel targets for therapeutics aimed at improving functioning and overall quality of life in individuals with serious mental illnesses, as well as quantitative phenotypes for use in early detection efforts.

Eligibility criteria

Qualifiers

18-55 years old

Experienced a psychotic disorder or mood disorder

Disqualifiers

Any neurological disorder or current substance use disorder (during the past 6 months)

Not proficient in English

A recent change in medication, or an acute symptom presentation

Standard exclusion criteria for participation in an MRI scan (e.g., presence of metal in the body, claustrophobia, a history of head trauma).

Trial design

Treatments tested in this trial

  • EMA

Treatment groups

120 Participants
are divided into 1 treatment group

Sponsors and collaborators

Massachusetts General Hospital

Lead sponsor

Boston University

Collaborator